TransMedics (TMDX) Shares Outstanding (2018 - 2026)

TransMedics has reported Shares Outstanding for 9 years, with the latest figure at $34.5 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding rose 2.12% year-over-year to $34.5 million; the trailing twelve-month figure through Mar 2026 stood at $34.5 million (up 2.12% YoY), and the FY2025 full-year result was $34.3 million, up 1.93% from the prior year.
• Shares Outstanding for Q1 2026 stood at $34.5 million, up from $34.3 million in the prior quarter.
• The five-year high for Shares Outstanding was $34.5 million in Q1 2026, with the low at $28.0 million in Q1 2022.
• Average Shares Outstanding over 5 years is $32.6 million, with a median of $32.9 million recorded in 2024.
• Year-over-year, Shares Outstanding gained 16.32% in 2023 and grew 0.98% in 2024.
• Tracing TMDX's Shares Outstanding over 5 years: stood at $32.1 million in 2022, then advanced by 1.65% to $32.7 million in 2023, then advanced by 2.9% to $33.6 million in 2024, then grew by 1.93% to $34.3 million in 2025, then gained by 0.81% to $34.5 million in 2026.
• The last three Shares Outstanding figures came in at $34.5 million (Q1 2026), $34.3 million (Q4 2025), and $34.1 million (Q3 2025), per Business Quant data.

Peer Comparison